Company: SION
Filing Date: 2025-03-20
Form Type: 8-K
Source: 0001193125-25-058306
Chunk: 0

Company: Sionna Therapeutics, Inc.
Filing Date: 2025-03-20
Form: 8-K
Item: Item 2.02
Chunk 0
---
Item 2.02      Results of Operations and Financial Condition.  

On March 20, 2025, Sionna Therapeutics, Inc. issued a press release announcing its financial results and business highlights for the fiscal year ended December 31, 2024. The full text of the press release is furnished as Exhibit 99.1 to this Current Report on Form8-Kand is incorporated herein by reference.

The information set forth under this Item 2.02 and in Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such filing.